Earnings Call/Transcript
Aequs Earnings Call Transcript Filed
Aequs filed the transcript of its Q2 and H1 FY27 earnings call held on October 26, 2026, covering unaudited financial results for the period ended September 30, 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY27
Investor Presentation
Q4 FY26
Investor Presentation
Q4 FY26
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone

Bearish
3
Neutral
4
Bullish
7
Bearish
32
Neutral
4
Bullish
10
Bearish
29
Neutral
0
Bullish
3
Bearish
29
Neutral
0
Bullish
3
Bearish
29
Neutral
0
Bullish
3
Bearish
29
Neutral
0
Bullish
3
Earnings Call/Transcript
Aequs filed the transcript of its Q2 and H1 FY27 earnings call held on October 26, 2026, covering unaudited financial results for the period ended September 30, 2026.
Regulatory/Compliance Filing
Aequs submitted CARE Ratings’ monitoring agency report for the quarter ended September 30, 2026, confirming no material deviation in the utilisation of Pre-IPO and IPO proceeds.
Financial Results
Aequs submitted newspaper publication copies of its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
Earnings Call/Transcript
Aequs has made available the audio recording of its earnings conference call on unaudited results for the quarter and half year ended September 30, 2026.
Other
Aequs’ NRC approved 2,00,000 employee stock options under ESOP 2025 for an eligible employee, exercisable at ₹235.50 per option after meeting vesting conditions.
Financial Results
Aequs reported consolidated Q2 FY27 revenue of ₹4,091 million, up 45% year on year, while EBITDA fell 45% and net loss widened to ₹522 million.
Aequs Ltd (AEQUS) is currently trading at 213.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aequs Limited manufactures precision aerospace components and assemblies, alongside consumer products including electronics components, toys, cookware and small appliances. Its aerospace portfolio spans engine systems, landing systems, structures, interiors, cargo and assemblies, while consumer manufacturing operates primarily through Bengaluru and Hubballi facilities and is still progressing toward consistent high-volume production. Aerospace is the clear earnings engine: Q2 FY27 revenue rose 44% year-on-year to INR3,514 million, with segment EBITDA of INR783 million and approximately 22% margin. Aerospace represented 86% of consolidated quarterly revenue, indicating that the company’s near-term financial performance remains substantially dependent on execution, utilization and growth within this segment. Aequs Limited’s aerospace order book reached USD1.1 billion, up 9% sequentially, while its product portfolio expanded to 5,978 parts. The addition of 238 parts during the quarter and a new Safran agreement demonstrate increasing customer wallet share and deeper program participation rather than merely capacity-led revenue growth. Consumer revenue continued growing but profitability deteriorated as qualification delays, supply constraints and customer transitions reduced utilization. Consumer EBITDA loss widened to INR401 million in Q2 FY27, and management recalibrated the earlier Q4 FY27 breakeven milestone, while retaining a longer-term objective of reaching consumer PAT positivity in FY30. The company is accelerating aerospace investment while pacing consumer capital deployment more cautiously. Promoter-group preferential warrants of INR6,500 million, alongside planned debt financing, are intended to fund Hosur development, capacity expansion, strategic joint ventures and working capital, but the capital raise also reflects materially higher funding requirements during the expansion phase.
Over the past 52 weeks, Aequs Ltd has traded between a low of ₹113.65 and a high of ₹294.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aequs Ltd has a market capitalization of approximately 14,640.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aequs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -72.42 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 14,640.63 Cr, Aequs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aequs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aequs Ltd is -72.42. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Aequs has scheduled its board meeting for October 26, 2026.
Aequs has signed a 15-year, single-source agreement with Safran Landing Systems to manufacture fully assembled Airbus A320 wheels at its Belagavi Aerospace SEZ facility.
The board approved a preferential issue of up to 2,80,71,690 warrants convertible into equity shares, aiming to raise about ₹650 crore from a promoter-group entity.
Aequs plans to consider a preferential issue of warrants convertible into equity shares to its promoter and to convene an EGM to seek shareholder approval.
Aerospace & Defense
Aerospace & Defense
14,285 Cr
Low Risk
-70.7
44.1
—
10.5
294.90
113.65
Sales CAGR
Profit CAGR
ROE
ROCE